Cargando…
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers
Biliary tract cancers (BTCs) consist of a group of highly heterogeneous malignancies that are characterized by genomic differences among tumors from different anatomic sites. The current treatment for BTC includes surgery, chemotherapy, target therapy, and immunotherapy. Although surgery remains the...
Autores principales: | Zhang, Ruyi, Puzzoni, Marco, Mariani, Stefano, Zheng, Yi, Liscia, Nicole, Guo, Yixuan, Donisi, Clelia, Liu, Yu, Impera, Valentino, Fang, Weijia, Scartozzi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645726/ https://www.ncbi.nlm.nih.gov/pubmed/34534382 http://dx.doi.org/10.1111/cas.15139 |
Ejemplares similares
-
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review
por: Massa, Elena, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021) -
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
por: Madeddu, Clelia, et al.
Publicado: (2022) -
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer
por: Lai, Eleonora, et al.
Publicado: (2020) -
How to improve metastatic pancreatic ductal adenocarcinoma patients’ selection: Between clinical trials and the real-world
por: Pretta, Andrea, et al.
Publicado: (2022)